{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T19:29:21Z","timestamp":1788895761753,"version":"build-2803163510"},"reference-count":141,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T00:00:00Z","timestamp":1716854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T00:00:00Z","timestamp":1716854400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Drugs"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1007\/s40272-024-00632-y","type":"journal-article","created":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T06:02:02Z","timestamp":1716876122000},"page":"381-395","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Diagnosis and Management of Pediatric Neuropsychiatric Systemic Lupus Erythematosus: An Update"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3043-792X","authenticated-orcid":false,"given":"Dilara","family":"Unal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6629-3967","authenticated-orcid":false,"given":"Veysel","family":"Cam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0138-8791","authenticated-orcid":false,"given":"Hulya Ercan","family":"Emreol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2883-7868","authenticated-orcid":false,"given":"Seza","family":"\u00d6zen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,28]]},"reference":[{"key":"632_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2019.108274","volume":"209","author":"EMD Smith","year":"2019","unstructured":"Smith EMD, Lythgoe H, Midgley A, Beresford MW, Hedrich CM. Juvenile-onset systemic lupus erythematosus: update on clinical presentation, pathophysiology and treatment options. Clin Immunol. 2019;209: 108274.","journal-title":"Clin Immunol"},{"issue":"12","key":"632_CR2","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1002\/acr.21757","volume":"64","author":"CA Silva","year":"2012","unstructured":"Silva CA, Avcin T, Brunner HI. Taxonomy for systemic lupus erythematosus with onset before adulthood. Arthritis Care Res (Hoboken). 2012;64(12):1787\u201393.","journal-title":"Arthritis Care Res (Hoboken)."},{"issue":"14","key":"632_CR3","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1177\/0961203316644333","volume":"25","author":"N Ambrose","year":"2016","unstructured":"Ambrose N, Morgan TA, Galloway J, Ionnoau Y, Beresford MW, Isenberg DA, UK JSLE Study Group. Differences in disease phenotype and severity in SLE across age groups. Lupus. 2016;25(14):1542\u201350.","journal-title":"Lupus"},{"issue":"4","key":"632_CR4","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.berh.2018.02.001","volume":"31","author":"CM Hedrich","year":"2017","unstructured":"Hedrich CM, Smith EM, Beresford MW. Juvenile-onset systemic lupus erythematosus (jSLE)\u2013Pathophysiological concepts and treatment options. Best Pract Res Clin Rheumatol. 2017;31(4):488\u2013504.","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"1","key":"632_CR5","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1136\/annrheumdis-2014-206334","volume":"75","author":"F Rees","year":"2016","unstructured":"Rees F, Doherty M, Grainge M, Davenport G, Lanyon P, Zhang W. The incidence and prevalence of systemic lupus erythematosus in the UK, 1999\u20132012. Ann Rheum Dis. 2016;75(1):136\u201341.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"632_CR6","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ncl.2009.09.004","volume":"28","author":"E Muscal","year":"2010","unstructured":"Muscal E, Brey RL. Neurologic manifestations of systemic lupus erythematosus in children and adults. Neurol Clin. 2010;28(1):61\u201373.","journal-title":"Neurol Clin"},{"issue":"12","key":"632_CR7","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1177\/09612033211045050","volume":"30","author":"T Giani","year":"2021","unstructured":"Giani T, Smith EM, Al-Abadi E, Armon K, Bailey K, Ciurtin C, et al. Neuropsychiatric involvement in juvenile-onset systemic lupus erythematosus: data from the UK Juvenile-onset systemic lupus erythematosus cohort study. Lupus. 2021;30(12):1955\u201365.","journal-title":"Lupus"},{"issue":"1","key":"632_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.semarthrit.2010.08.001","volume":"41","author":"A Unterman","year":"2011","unstructured":"Unterman A, Nolte JE, Boaz M, Abady M, Shoenfeld Y, Zandman-Goddard G. Neuropsychiatric syndromes in systemic lupus erythematosus: a meta-analysis. Semin Arthritis Rheum. 2011;41(1):1\u201311.","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"632_CR9","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/pr.2011.415","volume":"70","author":"D Maritsi","year":"2011","unstructured":"Maritsi D, Al-Obadi M, Melo-Gomes S, Edelsten C, Pilkington C. Systemic lupus erythematosus (SLE) complicated by neuromyelitis optica: case series from a Tertiary Paediatric Rheumatology Centre. Pediatr Res. 2011;70(5):190.","journal-title":"Pediatr Res"},{"issue":"5","key":"632_CR10","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1177\/09612033221088207","volume":"31","author":"R Baisya","year":"2022","unstructured":"Baisya R, Kumar Devarasetti P, Narayanan R, Rajasekhar L. Posterior reversible encephalopathy syndrome in juvenile lupus-a case series and literature review. Lupus. 2022;31(5):606\u201312.","journal-title":"Lupus"},{"key":"632_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12969-020-00449-2","volume":"18","author":"A Theisen","year":"2020","unstructured":"Theisen A, Bose P, Knight C, Oliver M. Leukoencephalopathy and cerebral edema as the presenting manifestations of SLE in an ANA-negative adolescent female: a case report and review of literature. Pediatr Rheumatol. 2020;18:1\u20139.","journal-title":"Pediatr Rheumatol"},{"issue":"3","key":"632_CR12","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.semarthrit.2005.08.008","volume":"35","author":"ER Vina","year":"2005","unstructured":"Vina ER, Fang AJ, Wallace DJ, Weisman MH. Chronic inflammatory demyelinating polyneuropathy in patients with systemic lupus erythematosus: prognosis and outcome. Semin Arthritis Rheum. 2005;35(3):175\u201384.","journal-title":"Semin Arthritis Rheum"},{"issue":"12","key":"632_CR13","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1007\/s00296-009-0887-6","volume":"29","author":"S Singh","year":"2009","unstructured":"Singh S, Gupta MK, Ahluwalia J, Singh P, Malhi P. Neuropsychiatric manifestations and antiphospholipid antibodies in pediatric onset lupus: 14 years of experience from a tertiary center of North India. Rheumatol Int. 2009;29(12):1455\u201361.","journal-title":"Rheumatol Int"},{"issue":"4","key":"632_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2023.105559","volume":"90","author":"AP K\u0131saarslan","year":"2023","unstructured":"K\u0131saarslan AP, \u00c7i\u00e7ek S, Batu ED, \u015eahin S, G\u00fcrg\u00f6ze MK, \u00c7etinkaya SB, et al. Neuropsychiatric involvement in juvenile-onset systemic lupus erythematosus: a multicenter study. Jt Bone Spine. 2023;90(4): 105559.","journal-title":"Jt Bone Spine"},{"issue":"14","key":"632_CR15","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1177\/0961203316644333","volume":"25","author":"N Ambrose","year":"2016","unstructured":"Ambrose N, Morgan T, Galloway J, Ionnoau Y, Beresford M, Isenberg D. Differences in disease phenotype and severity in SLE across age groups. Lupus. 2016;25(14):1542\u201350.","journal-title":"Lupus"},{"issue":"6","key":"632_CR16","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1093\/rheumatology\/ket488","volume":"53","author":"B Amaral","year":"2014","unstructured":"Amaral B, Murphy G, Ioannou Y, Isenberg DA. A comparison of the outcome of adolescent and adult-onset systemic lupus erythematosus. Rheumatology. 2014;53(6):1130\u20135.","journal-title":"Rheumatology"},{"issue":"12","key":"632_CR17","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1177\/0961203315591024","volume":"24","author":"J Choi","year":"2015","unstructured":"Choi J, Park D, Kang J, Yim Y, Lee K, Lee J, et al. Comparison of clinical and serological differences among juvenile-, adult-, and late-onset systemic lupus erythematosus in Korean patients. Lupus. 2015;24(12):1342\u20139.","journal-title":"Lupus"},{"issue":"Supplement 5","key":"632_CR18","doi-asserted-by":"publisher","first-page":"v52","DOI":"10.1093\/rheumatology\/keaa404","volume":"59","author":"M Govoni","year":"2020","unstructured":"Govoni M, Hanly JG. The management of neuropsychiatric lupus in the 21st century: still so many unmet needs? Rheumatology. 2020;59(Supplement 5):v52\u201362.","journal-title":"Rheumatology"},{"issue":"11","key":"632_CR19","first-page":"2156","volume":"31","author":"JG Hanly","year":"2004","unstructured":"Hanly JG, McCurdy G, Fougere L, Douglas J-A, Thompson K. Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance. J Rheumatol. 2004;31(11):2156\u201362.","journal-title":"J Rheumatol"},{"issue":"4","key":"632_CR20","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1177\/0961203307087875","volume":"17","author":"L Tucker","year":"2008","unstructured":"Tucker L, Uribe A, Fernandez M, Vila L, McGwin G, Apte M, et al. Adolescent onset of lupus results in more aggressive disease and worse outcomes: results of a nested matched case\u2013control study within LUMINA, a multiethnic US cohort (LUMINA LVII). Lupus. 2008;17(4):314\u201322.","journal-title":"Lupus"},{"issue":"6","key":"632_CR21","first-page":"1047","volume":"35","author":"V Torrente-Segarra","year":"2017","unstructured":"Torrente-Segarra V, Salman Monte TC, R\u00faa-Figueroa I, S\u00e1nchez-Alonso F, L\u00f3pez-Longo FJ, Galindo-Izquierdo M, et al. Juvenile-and adult-onset systemic lupus erythematosus: a comparative study in a large cohort from the Spanish Society of Rheumatology Lupus Registry (RELESSER). Clin Exp Rheumatol. 2017;35(6):1047\u201355.","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"632_CR22","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1093\/rheumatology\/keu384","volume":"54","author":"A Bortoluzzi","year":"2015","unstructured":"Bortoluzzi A, Scire CA, Bombardieri S, Caniatti L, Conti F, De Vita S, et al. Development and validation of a new algorithm for attribution of neuropsychiatric events in systemic lupus erythematosus. Rheumatology. 2015;54(5):891\u20138.","journal-title":"Rheumatology"},{"issue":"2","key":"632_CR23","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1002\/art.23204","volume":"58","author":"HI Brunner","year":"2008","unstructured":"Brunner HI, Gladman DD, Iba\u00f1ez D, Urowitz MD, Silverman ED. Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus. Arthritis Rheum. 2008;58(2):556\u201362.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"632_CR24","doi-asserted-by":"publisher","first-page":"e153","DOI":"10.3928\/00904481-20150611-11","volume":"44","author":"A Soybilgic","year":"2015","unstructured":"Soybilgic A. Neuropsychiatric systemic lupus erythematosus in children. Pediatr Ann. 2015;44(6):e153\u20138.","journal-title":"Pediatr Ann"},{"key":"632_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/2548142","volume":"2018","author":"M-A Khajezadeh","year":"2018","unstructured":"Khajezadeh M-A, Zamani G, Moazzami B, Nagahi Z, Mousavi-Torshizi M, Ziaee V. Neuropsychiatric involvement in juvenile-onset systemic lupus erythematosus. Neurol Res Int. 2018;2018:1\u20137.","journal-title":"Neurol Res Int"},{"issue":"10","key":"632_CR26","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1177\/0961203306070990","volume":"15","author":"H Yu","year":"2006","unstructured":"Yu H, Lee J, Wang L, Yang Y, Chiang BL. Neuropsychiatric manifestations in pediatric systemic lupus erythematosus: a 20-year study. Lupus. 2006;15(10):651\u20137.","journal-title":"Lupus"},{"issue":"3","key":"632_CR27","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.pediatrneurol.2014.03.027","volume":"51","author":"YCZ Zambrano","year":"2014","unstructured":"Zambrano YCZ, Ramos JDG, Vargas NEP, Ramirez DCB, Rodriguez SMR, Ni\u00f1o ACV, et al. Risk factors for neuropsychiatric manifestations in children with systemic lupus erythematosus: case-control study. Pediatr Neurol. 2014;51(3):403\u20139.","journal-title":"Pediatr Neurol"},{"issue":"8","key":"632_CR28","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/S2352-4642(22)00157-2","volume":"6","author":"S Appenzeller","year":"2022","unstructured":"Appenzeller S, Pereira DR, Julio PR, Reis F, Rittner L, Marini R. Neuropsychiatric manifestations in childhood-onset systemic lupus erythematosus. Lancet Child Adolesc Health. 2022;6(8):571\u201381.","journal-title":"Lancet Child Adolesc Health."},{"issue":"5","key":"632_CR29","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1097\/RHU.0000000000001029","volume":"27","author":"FPST Santos","year":"2021","unstructured":"Santos FPST, Nascimento BR, Calderaro DC, Ferreira GA, Correa H. Neuropsychiatric syndromes in childhood-onset systemic lupus erythematosus: a systematic review and meta-analysis. JCR J Clin Rheumatol. 2021;27(5):206\u201314.","journal-title":"JCR J Clin Rheumatol."},{"issue":"9","key":"632_CR30","first-page":"1873","volume":"33","author":"L Harel","year":"2006","unstructured":"Harel L, Sandborg C, Lee T, von Scheven E. Neuropsychiatric manifestations in pediatric systemic lupus erythematosus and association with antiphospholipid antibodies. J Rheumatol. 2006;33(9):1873\u20137.","journal-title":"J Rheumatol"},{"issue":"4","key":"632_CR31","doi-asserted-by":"publisher","first-page":"506","DOI":"10.3899\/jrheum.120675","volume":"40","author":"LSH Lim","year":"2013","unstructured":"Lim LSH, Lefebvre A, Benseler S, Peralta M, Silverman ED. Psychiatric illness of systemic lupus erythematosus in childhood: spectrum of clinically important manifestations. J Rheumatol. 2013;40(4):506\u201312.","journal-title":"J Rheumatol"},{"key":"632_CR32","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s10067-004-0898-3","volume":"23","author":"MO Olfat","year":"2004","unstructured":"Olfat MO, Al-Mayouf SM, Muzaffer MA. Pattern of neuropsychiatric manifestations and outcome in juvenile systemic lupus erythematosus. Clin Rheumatol. 2004;23:395\u20139.","journal-title":"Clin Rheumatol"},{"issue":"12","key":"632_CR33","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1111\/j.1469-8749.2010.03793.x","volume":"52","author":"I Abu-Arafeh","year":"2010","unstructured":"Abu-Arafeh I, Razak S, Sivaraman B, Graham C. Prevalence of headache and migraine in children and adolescents: a systematic review of population-based studies. Dev Med Child Neurol. 2010;52(12):1088\u201397.","journal-title":"Dev Med Child Neurol"},{"issue":"5","key":"632_CR34","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1093\/brain\/awh146","volume":"127","author":"DD Mitsikostas","year":"2004","unstructured":"Mitsikostas DD, Sfikakis PP, Goadsby PJ. A meta-analysis for headache in systemic lupus erythematosus: the evidence and the myth. Brain. 2004;127(5):1200\u20139.","journal-title":"Brain"},{"issue":"12","key":"632_CR35","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1191\/0961203303lu506oa","volume":"12","author":"M Cuadrado","year":"2003","unstructured":"Cuadrado M, Sanna G. Headache and systemic lupus erythematosus. Lupus. 2003;12(12):943\u20136.","journal-title":"Lupus"},{"issue":"8","key":"632_CR36","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1177\/0961203307078971","volume":"16","author":"S Benseler","year":"2007","unstructured":"Benseler S, Silverman ED. Neuropsychiatric involvement in pediatric systemic lupus erythematosus. Lupus. 2007;16(8):564\u201371.","journal-title":"Lupus"},{"issue":"4","key":"632_CR37","first-page":"257","volume":"19","author":"A Mahdavi Adeli","year":"2016","unstructured":"Mahdavi Adeli A, Haghighi A, Malakouti SK. Prevalence of cognitive disorders in patients with systemic lupus erythromatosus; a cross-sectional study in Rasoul-e-Akram Hospital, Tehran Iran. Arch Iran Med. 2016;19(4):257\u201361.","journal-title":"Arch Iran Med"},{"issue":"7","key":"632_CR38","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1002\/art.23005","volume":"57","author":"HI Brunner","year":"2007","unstructured":"Brunner HI, Ruth NM, German A, Nelson S, Passo MH, Roebuck-Spencer T, et al. Initial validation of the pediatric automated neuropsychological assessment metrics for childhood-onset systemic lupus erythematosus. Arthritis Care Res. 2007;57(7):1174\u201382.","journal-title":"Arthritis Care Res"},{"issue":"5","key":"632_CR39","first-page":"923","volume":"15","author":"W Sibbitt","year":"1994","unstructured":"Sibbitt W, Haseler LJ, Griffey RH, Hart BL, Sibbitt RR, Matwiyoff NA. Analysis of cerebral structural changes in systemic lupus erythematosus by proton MR spectroscopy. Am J Neuroradiol. 1994;15(5):923\u20138.","journal-title":"Am J Neuroradiol"},{"key":"632_CR40","first-page":"52","volume-title":"Lupus and the brain: advances in neuropsychiatric systemic lupus erythematosus","author":"A Fanouriakis","year":"2019","unstructured":"Fanouriakis A, Bertsias G, Govoni M. Lupus and the brain: advances in neuropsychiatric systemic lupus erythematosus. Frontiers Media SA; 2019. p. 52."},{"issue":"8","key":"632_CR41","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1002\/art.23098","volume":"57","author":"P Tomietto","year":"2007","unstructured":"Tomietto P, Annese V, D\u2019agostini S, Venturini P, La Torre G, De Vita S, et al. General and specific factors associated with severity of cognitive impairment in systemic lupus erythematosus. Arthritis Care Res. 2007;57(8):1461\u201372.","journal-title":"Arthritis Care Res"},{"key":"632_CR42","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s12026-015-8713-6","volume":"63","author":"PT Huerta","year":"2015","unstructured":"Huerta PT, Gibson EL, Rey C, Huerta TS. Integrative neuroscience approach to neuropsychiatric lupus. Immunol Res. 2015;63:11\u20137.","journal-title":"Immunol Res"},{"issue":"10","key":"632_CR43","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1093\/rheumatology\/ken260","volume":"47","author":"JM Pego-Reigosa","year":"2008","unstructured":"Pego-Reigosa JM, Isenberg DA. Psychosis due to systemic lupus erythematosus: characteristics and long-term outcome of this rare manifestation of the disease. Rheumatology. 2008;47(10):1498\u2013502.","journal-title":"Rheumatology"},{"issue":"12","key":"632_CR44","doi-asserted-by":"publisher","first-page":"5620","DOI":"10.1093\/rheumatology\/keab160","volume":"60","author":"E Abrol","year":"2021","unstructured":"Abrol E, Coutinho E, Chou M, Hart M, Vincent A, Howard R, et al. Psychosis in systemic lupus erythematosus (SLE): 40-year experience of a specialist centre. Rheumatology (Oxford). 2021;60(12):5620\u20139.","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"632_CR45","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1212\/WNL.61.1.104","volume":"61","author":"SY Chau","year":"2003","unstructured":"Chau SY, Mok CC. Factors predictive of corticosteroid psychosis in patients with systemic lupus erythematosus. Neurology. 2003;61(1):104\u20137.","journal-title":"Neurology"},{"issue":"5","key":"632_CR46","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/0002-9343(75)90500-8","volume":"58","author":"JS Sergent","year":"1975","unstructured":"Sergent JS, Lockshin MD, Klempner MS, Lipsky BA. Central nervous system disease in systemic lupus erythematosus: therapy and prognosis. Am J Med. 1975;58(5):644\u201354.","journal-title":"Am J Med"},{"issue":"1","key":"632_CR47","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1002\/art.21539","volume":"54","author":"FB Karassa","year":"2006","unstructured":"Karassa FB, Afeltra A, Ambrozic A, Chang DM, De Keyser F, Doria A, et al. Accuracy of anti\u2013ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus: an international meta-analysis. Arthritis Rheum. 2006;54(1):312\u201324.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"632_CR48","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.rcreue.2018.11.003","volume":"26","author":"J-D Mar\u00edn","year":"2019","unstructured":"Mar\u00edn J-D, Posso-Osorio I, Vargas S, Nieto-Aristiz\u00e1bal I, R\u00edos-Serna LJ, Tob\u00f3n GJ. Antibodies associated with neuropsychiatric lupus: pathophysiological role, prevalence and diagnostic usefulness. Revista Colombiana de Reumatolog\u00eda (English Edition). 2019;26(2):111\u20137.","journal-title":"Revista Colombiana de Reumatolog\u00eda (English Edition)."},{"issue":"10","key":"632_CR49","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1136\/ard.2010.148502","volume":"70","author":"JG Hanly","year":"2011","unstructured":"Hanly JG, Urowitz MB, Su L, Bae S-C, Gordon C, Clarke A, et al. Autoantibodies as biomarkers for the prediction of neuropsychiatric events in systemic lupus erythematosus. Ann Rheum Dis. 2011;70(10):1726\u201332.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"632_CR50","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/ene.14077","volume":"27","author":"L Hopia","year":"2020","unstructured":"Hopia L, Andersson M, Svenungsson E, Khademi M, Piehl F, Tomson T. Epilepsy in systemic lupus erythematosus: prevalence and risk factors. Eur J Neurol. 2020;27(2):297\u2013307.","journal-title":"Eur J Neurol"},{"issue":"6","key":"632_CR51","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1136\/ard.2007.077594","volume":"67","author":"R Andrade","year":"2008","unstructured":"Andrade R, Alarcon G, Gonzalez L, Fernandez M, Apte M, Vila L, et al. Seizures in patients with systemic lupus erythematosus: data from LUMINA, a multiethnic cohort (LUMINA LIV). Ann Rheum Dis. 2008;67(6):829\u201334.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"632_CR52","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/0961203316666961","volume":"26","author":"A Rosati","year":"2017","unstructured":"Rosati A, Guerrini R, Cimaz R. Lupus, antiphospholipid syndrome and epilepsy: an update. Lupus. 2017;26(1):3\u20135.","journal-title":"Lupus"},{"issue":"3","key":"632_CR53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0119911","volume":"10","author":"T Hawro","year":"2015","unstructured":"Hawro T, Bogucki A, Krupi\u0144ska-Kun M, Maurer M, Wo\u017aniacka A. Intractable headaches, ischemic stroke, and seizures are linked to the presence of anti-\u03b22GPI antibodies in patients with systemic lupus erythematosus. PLoS ONE. 2015;10(3): e0119911.","journal-title":"PLoS ONE"},{"issue":"3","key":"632_CR54","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1097\/00005792-199705000-00006","volume":"76","author":"R Cervera","year":"1997","unstructured":"Cervera R, Asherson RA, Font J, Tikly M, Pallar\u00e9s L, Chamorro A, et al. Chorea in the antiphospholipid syndrome. Clinical, radiologic, and immunologic characteristics of 50 patients from our clinics and the recent literature. Medicine. 1997;76(3):203\u201312.","journal-title":"Medicine"},{"key":"632_CR55","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1007\/s00702-013-1023-z","volume":"120","author":"JF Baizabal-Carvallo","year":"2013","unstructured":"Baizabal-Carvallo JF, Bonnet C, Jankovic J. Movement disorders in systemic lupus erythematosus and the antiphospholipid syndrome. J Neural Transm. 2013;120:1579\u201389.","journal-title":"J Neural Transm"},{"issue":"2","key":"632_CR56","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1097\/RHU.0b013e31820e7c8d","volume":"17","author":"JF Baizabal-Carvallo","year":"2011","unstructured":"Baizabal-Carvallo JF, Alonso-Juarez M, Koslowski M. Chorea in systemic lupus erythematosus. JCR J Clin Rheumatol. 2011;17(2):69\u201372.","journal-title":"JCR J Clin Rheumatol."},{"key":"632_CR57","first-page":"121","volume":"13","author":"S Yeap","year":"2010","unstructured":"Yeap S, Gun S. Characteristics of Malaysian systemic lupus erythematosus (SLE) patients seen in a public and private hospital. Int J Rheum Dis. 2010;13:121.","journal-title":"Int J Rheum Dis"},{"issue":"2","key":"632_CR58","first-page":"280","volume":"31","author":"DP D\u2019Cruz","year":"2004","unstructured":"D\u2019Cruz DP, Mellor-Pita S, Joven B, Sanna G, Allanson J, Taylor J, et al. Transverse myelitis as the first manifestation of systemic lupus erythematosus or lupus-like disease: good functional outcome and relevance of antiphospholipid antibodies. J Rheumatol. 2004;31(2):280\u20135.","journal-title":"J Rheumatol"},{"issue":"3","key":"632_CR59","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1159\/000186504","volume":"61","author":"JF Baizabal-Carvallo","year":"2009","unstructured":"Baizabal-Carvallo JF, Delgadillo-M\u00e1rquez G, Esta\u00f1ol B, Garc\u00eda-Ramos G. Clinical characteristics and outcomes of the meningitides in systemic lupus erythematosus. Eur Neurol. 2009;61(3):143\u20138.","journal-title":"Eur Neurol"},{"issue":"11","key":"632_CR60","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1001\/jama.1978.03280380062020","volume":"239","author":"HL Widener","year":"1978","unstructured":"Widener HL, Littman BH. Ibuprofen-induced meningitis in systemic lupus erythematosus. JAMA. 1978;239(11):1062\u20134.","journal-title":"JAMA"},{"issue":"6","key":"632_CR61","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1001\/jama.240.6.529c","volume":"240","author":"JS Sergent","year":"1978","unstructured":"Sergent JS, Lockshin M. Azathioprine-induced meningitis in systemic lupus erythematosus. JAMA. 1978;240(6):529.","journal-title":"JAMA"},{"issue":"1","key":"632_CR62","doi-asserted-by":"publisher","first-page":"7","DOI":"10.31138\/mjr.30.1.7","volume":"30","author":"D Nikolopoulos","year":"2019","unstructured":"Nikolopoulos D, Fanouriakis A, Boumpas DT. Cerebrovascular events in systemic lupus erythematosus: diagnosis and management. Mediterranean J Rheumatol. 2019;30(1):7\u201315.","journal-title":"Mediterranean J Rheumatol."},{"issue":"12","key":"632_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102693","volume":"19","author":"AG Islab\u00e3o","year":"2020","unstructured":"Islab\u00e3o AG, Mota LM, Ribeiro MCM, Arabi TM, Cividatti GN, Queiroz LB, et al. Childhood-onset systemic lupus erythematosus-related antiphospholipid syndrome: a multicenter study with 1519 patients. Autoimmun Rev. 2020;19(12): 102693.","journal-title":"Autoimmun Rev"},{"issue":"11","key":"632_CR64","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000625","volume":"94","author":"W Xianbin","year":"2015","unstructured":"Xianbin W, Mingyu W, Dong X, Huiying L, Yan X, Fengchun Z, et al. Peripheral neuropathies due to systemic lupus erythematosus in China. Medicine. 2015;94(11): e625.","journal-title":"Medicine"},{"issue":"2","key":"632_CR65","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.semarthrit.2011.04.001","volume":"41","author":"B Florica","year":"2011","unstructured":"Florica B, Aghdassi E, Su J, Gladman DD, Urowitz MB, Fortin PR. Peripheral neuropathy in patients with systemic lupus erythematosus. Semin Arthritis Rheum. 2011;41(2):203\u201311.","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"632_CR66","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s40348-023-00161-7","volume":"10","author":"V Natoli","year":"2023","unstructured":"Natoli V, Charras A, Hahn G, Hedrich CM. Neuropsychiatric involvement in juvenile-onset systemic lupus erythematosus (jSLE). Mol Cell Pediatr. 2023;10(1):5.","journal-title":"Mol Cell Pediatr."},{"issue":"7","key":"632_CR67","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1136\/jcp.56.7.481","volume":"56","author":"CC Mok","year":"2003","unstructured":"Mok CC, Lau CS. Pathogenesis of systemic lupus erythematosus. J Clin Pathol. 2003;56(7):481\u201390. https:\/\/doi.org\/10.1136\/jcp.56.7.481.","journal-title":"J Clin Pathol"},{"issue":"10","key":"632_CR68","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/nrneurol.2014.148","volume":"10","author":"H Jeltsch-David","year":"2014","unstructured":"Jeltsch-David H, Muller S. Neuropsychiatric systemic lupus erythematosus: pathogenesis and biomarkers. Nat Rev Neurol. 2014;10(10):579\u201396.","journal-title":"Nat Rev Neurol"},{"issue":"5","key":"632_CR69","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.semarthrit.2006.11.003","volume":"36","author":"G Zandman-Goddard","year":"2007","unstructured":"Zandman-Goddard G, Chapman J, Shoenfeld Y. Autoantibodies involved in neuropsychiatric SLE and antiphospholipid syndrome. Semin Arthritis Rheum. 2007;36(5):297\u2013315.","journal-title":"Semin Arthritis Rheum"},{"issue":"10","key":"632_CR70","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1212\/01.WNL.0000144178.32208.4F","volume":"63","author":"S Appenzeller","year":"2004","unstructured":"Appenzeller S, Cendes F, Costallat LT. Epileptic seizures in systemic lupus erythematosus. Neurology. 2004;63(10):1808\u201312.","journal-title":"Neurology"},{"key":"632_CR71","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s42358-023-00300-8","volume":"63","author":"FPST Santos","year":"2023","unstructured":"Santos FPST, Ferreira GA, Paula JJd, Souza KCPd, Silva SLC, Correa H. Cognitive dysfunction in patients with childhood-onset systemic lupus erythematosus may impact treatment. Adv Rheumatol. 2023;63:18.","journal-title":"Adv Rheumatol."},{"issue":"4","key":"632_CR72","first-page":"622","volume":"32","author":"MY Mok","year":"2005","unstructured":"Mok MY, Chan EYT, Fong DYT, Leung KFS, Wong WS, Lau CS. Antiphospholipid antibody profiles and their clinical associations in Chinese patients with systemic lupus erythematosus. J Rheumatol. 2005;32(4):622\u20138.","journal-title":"J Rheumatol"},{"issue":"5","key":"632_CR73","first-page":"985","volume":"30","author":"G Sanna","year":"2003","unstructured":"Sanna G, Bertolaccini ML, Cuadrado MJ, Laing H, Khamashta MA, Mathieu A, et al. Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies. J Rheumatol. 2003;30(5):985\u201392.","journal-title":"J Rheumatol"},{"issue":"3","key":"632_CR74","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1177\/1352458517699791","volume":"24","author":"N Asgari","year":"2018","unstructured":"Asgari N, Jarius S, Laustrup H, Skejoe HP, Lillevang ST, Weinshenker BG, Voss A. Aquaporin-4-autoimmunity in patients with systemic lupus erythematosus: a predominantly population-based study. Mult Scler. 2018;24(3):331\u20139.","journal-title":"Mult Scler"},{"issue":"3","key":"632_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102463","volume":"19","author":"MY Choi","year":"2020","unstructured":"Choi MY, FitzPatrick RD, Buhler K, Mahler M, Fritzler MJ. A review and meta-analysis of anti-ribosomal P autoantibodies in systemic lupus erythematosus. Autoimmun Rev. 2020;19(3): 102463.","journal-title":"Autoimmun Rev"},{"issue":"1","key":"632_CR76","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2019-000359","volume":"6","author":"S Hirohata","year":"2019","unstructured":"Hirohata S, Tanaka K. Differential expression of antibodies to NMDA receptor in anti-NMDA receptor encephalitis and in neuropsychiatric systemic lupus erythematosus. Lupus Sci Med. 2019;6(1): e000359.","journal-title":"Lupus Sci Med."},{"issue":"5","key":"632_CR77","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1093\/rheumatology\/key282","volume":"58","author":"A-K Pr\u00f6bstel","year":"2019","unstructured":"Pr\u00f6bstel A-K, Thanei M, Erni B, Lecourt A-C, Branco L, Andr\u00e9 R, et al. Association of antibodies against myelin and neuronal antigens with neuroinflammation in systemic lupus erythematosus. Rheumatology. 2019;58(5):908\u201313.","journal-title":"Rheumatology"},{"issue":"10","key":"632_CR78","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0003347","volume":"3","author":"H Fragoso-Loyo","year":"2008","unstructured":"Fragoso-Loyo H, Cabiedes J, Orozco-Narv\u00e1ez A, D\u00e1vila-Maldonado L, Atisha-Fregoso Y, Diamond B, et al. Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis. PLoS ONE. 2008;3(10): e3347.","journal-title":"PLoS ONE"},{"issue":"2","key":"632_CR79","doi-asserted-by":"publisher","first-page":"R77","DOI":"10.1186\/ar4518","volume":"16","author":"S Hirohata","year":"2014","unstructured":"Hirohata S, Arinuma Y, Yanagida T, Yoshio T. Blood-brain barrier damages and intrathecal synthesis of anti-N-methyl-d-aspartate receptor NR2 antibodies in diffuse psychiatric\/neuropsychological syndromes in systemic lupus erythematosus. Arthritis Res Ther. 2014;16(2):R77.","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"632_CR80","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1111\/j.1468-1331.2004.00976.x","volume":"12","author":"R Omdal","year":"2005","unstructured":"Omdal R, Brokstad K, Waterloo K, Koldingsnes W, Jonsson R, Mellgren SI. Neuropsychiatric disturbances in SLE are associated with antibodies against NMDA receptors. Eur J Neurol. 2005;12(5):392\u20138.","journal-title":"Eur J Neurol"},{"issue":"5","key":"632_CR81","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1186\/s13075-014-0450-z","volume":"16","author":"S Hirohata","year":"2014","unstructured":"Hirohata S, Sakuma Y, Yanagida T, Yoshio T. Association of cerebrospinal fluid anti-Sm antibodies with acute confusional state in systemic lupus erythematosus. Arthritis Res Ther. 2014;16(5):450.","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"632_CR82","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1093\/rheumatology\/kew341","volume":"56","author":"D Cohen","year":"2017","unstructured":"Cohen D, Rijnink EC, Nabuurs RJ, Steup-Beekman GM, Versluis MJ, Emmer BJ, et al. Brain histopathology in patients with systemic lupus erythematosus: identification of lesions associated with clinical neuropsychiatric lupus syndromes and the role of complement. Rheumatology (Oxford). 2017;56(1):77\u201386.","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"632_CR83","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1177\/0961203316643170","volume":"25","author":"C Magro-Checa","year":"2016","unstructured":"Magro-Checa C, Schaarenburg RA, Beaart HJ, Huizinga TW, Steup-Beekman GM, Trouw LA. Complement levels and anti-C1q autoantibodies in patients with neuropsychiatric systemic lupus erythematosus. Lupus. 2016;25(8):878\u201388.","journal-title":"Lupus"},{"issue":"12","key":"632_CR84","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1002\/1529-0131(199912)42:12<2729::AID-ANR35>3.0.CO;2-I","volume":"42","author":"S Hirohata","year":"1999","unstructured":"Hirohata S, Hayakawa K. Enhanced interleukin-6 messenger RNA expression by neuronal cells in a patient with neuropsychiatric systemic lupus erythematosus. Arthritis Rheum. 1999;42(12):2729\u201330.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"632_CR85","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1002\/art.1780350410","volume":"35","author":"S Shiozawa","year":"1992","unstructured":"Shiozawa S, Kuroki Y, Kim M, Hirohata S, Ogino T. Interferon-alpha in lupus psychosis. Arthritis Rheum. 1992;35(4):417\u201322.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"632_CR86","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1136\/ard.58.2.85","volume":"58","author":"MJ Rood","year":"1999","unstructured":"Rood MJ, Keijsers V, van der Linden MW, Tong TQ, Borggreve SE, Verweij CL, et al. Neuropsychiatric systemic lupus erythematosus is associated with imbalance in interleukin 10 promoter haplotypes. Ann Rheum Dis. 1999;58(2):85\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"632_CR87","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1093\/rheumatology\/36.2.190","volume":"36","author":"R Gilad","year":"1997","unstructured":"Gilad R, Lampl Y, Eshel Y, Barak V, Sarova-Pinhas I. Cerebrospinal fluid soluble interleukin-2 receptor in cerebral lupus. Br J Rheumatol. 1997;36(2):190\u20133.","journal-title":"Br J Rheumatol"},{"issue":"7","key":"632_CR88","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1177\/096120330000900704","volume":"9","author":"E Trysberg","year":"2000","unstructured":"Trysberg E, Carlsten H, Tarkowski A. Intrathecal cytokines in systemic lupus erythematosus with central nervous system involvement. Lupus. 2000;9(7):498\u2013503.","journal-title":"Lupus"},{"issue":"11","key":"632_CR89","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1136\/annrheumdis-2016-210960","volume":"76","author":"N Groot","year":"2017","unstructured":"Groot N, de Graeff N, Avcin T, Bader-Meunier B, Brogan P, Dolezalova P, Feldman B, Kone-Paut I, Lahdenne P, Marks SD, McCann L, Ozen S, Pilkington C, Ravelli A, Royen-Kerkhof AV, Uziel Y, Vastert B, Wulffraat N, Kamphuis S, Beresford MW. European evidence-based recommendations for diagnosis and treatment of childhood-onset systemic lupus erythematosus: the SHARE initiative. Ann Rheum Dis. 2017;76(11):1788\u201396.","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 2","key":"632_CR90","doi-asserted-by":"publisher","first-page":"i76","DOI":"10.1136\/annrheumdis-2012-202369","volume":"72","author":"GM Steup-Beekman","year":"2013","unstructured":"Steup-Beekman GM, Zirkzee EJ, Cohen D, Gahrmann BM, Emmer BJ, Steens SC, Bollen EL, van Buchem MA, Huizinga TW. Neuropsychiatric manifestations in patients with systemic lupus erythematosus: epidemiology and radiology pointing to an immune-mediated cause. Ann Rheum Dis. 2013;72(Suppl 2):i76\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"632_CR91","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1136\/ard.2010.130476","volume":"69","author":"G Bertsias","year":"2010","unstructured":"Bertsias G, Ioannidis J, Aringer M, Bollen E, Bombardieri S, Bruce I, et al. EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs. Ann Rheum Dis. 2010;69(12):2074\u201382.","journal-title":"Ann Rheum Dis"},{"key":"632_CR92","doi-asserted-by":"crossref","unstructured":"Cohen D, Rijnink EC, Nabuurs RJ, Steup-Beekman GM, Versluis MJ, Emmer BJ, et al. Brain histopathology in patients with systemic lupus erythematosus: identification of lesions associated with clinical neuropsychiatric lupus syndromes and the role of complement. Rheumatology. 2016:kew341.","DOI":"10.1093\/rheumatology\/kew341"},{"issue":"3","key":"632_CR93","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1002\/art.30157","volume":"63","author":"J Luyendijk","year":"2011","unstructured":"Luyendijk J, Steens S, Ouwendijk W, Steup-Beekman G, Bollen E, Van Der Grond J, et al. Neuropsychiatric systemic lupus erythematosus: lessons learned from magnetic resonance imaging. Arthritis Rheum. 2011;63(3):722\u201332.","journal-title":"Arthritis Rheum"},{"key":"632_CR94","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1007\/s10067-016-3376-9","volume":"35","author":"M Al-Obaidi","year":"2016","unstructured":"Al-Obaidi M, Saunders D, Brown S, Ramsden L, Martin N, Moraitis E, et al. Evaluation of magnetic resonance imaging abnormalities in juvenile onset neuropsychiatric systemic lupus erythematosus. Clin Rheumatol. 2016;35:2449\u201356.","journal-title":"Clin Rheumatol"},{"issue":"7","key":"632_CR95","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1002\/acr.20152","volume":"62","author":"GS Ross","year":"2010","unstructured":"Ross GS, Zelko F, Klein-Gitelman M, Levy DM, Muscal E, Schanberg LE, et al. A proposed framework to standardize the neurocognitive assessment of patients with pediatric systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2010;62(7):1029\u201333.","journal-title":"Arthritis Care Res (Hoboken)."},{"issue":"7","key":"632_CR96","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1002\/art.23005","volume":"57","author":"HI Brunner","year":"2007","unstructured":"Brunner HI, Ruth NM, German A, Nelson S, Passo MH, Roebuck-Spencer T, et al. Initial validation of the Pediatric Automated Neuropsychological Assessment Metrics for childhood-onset systemic lupus erythematosus. Arthrit Rheum. 2007;57(7):1174\u201382.","journal-title":"Arthrit Rheum"},{"issue":"8","key":"632_CR97","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1002\/acr.20489","volume":"63","author":"TS Williams","year":"2011","unstructured":"Williams TS, Aranow C, Ross GS, Barsdorf A, Imundo LF, Eichenfield AH, et al. Neurocognitive impairment in childhood-onset systemic lupus erythematosus: measurement issues in diagnosis. Arthritis Care Res (Hoboken). 2011;63(8):1178\u201387.","journal-title":"Arthritis Care Res (Hoboken)."},{"issue":"4","key":"632_CR98","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1002\/1529-0131(199904)42:4<735::AID-ANR17>3.0.CO;2-L","volume":"42","author":"S Menon","year":"1999","unstructured":"Menon S, Jameson-Shortall E, Newman SP, Hall-Craggs MR, Chinn R, Isenberg DA. A longitudinal study of anticardiolipin antibody levels and cognitive functioning in systemic lupus erythematosus. Arthrit Rheum. 1999;42(4):735\u201341.","journal-title":"Arthrit Rheum"},{"issue":"1\u20132","key":"632_CR99","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jneuroim.2014.04.003","volume":"272","author":"A Katzav","year":"2014","unstructured":"Katzav A, Ben-Ziv T, Blank M, Pick CG, Shoenfeld Y, Chapman J. Antibody-specific behavioral effects: intracerebroventricular injection of antiphospholipid antibodies induces hyperactive behavior while anti-ribosomal-P antibodies induces depression and smell deficits in mice. J Neuroimmunol. 2014;272(1\u20132):10\u20135.","journal-title":"J Neuroimmunol"},{"issue":"12","key":"632_CR100","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1136\/ard.2010.130476","volume":"69","author":"GK Bertsias","year":"2010","unstructured":"Bertsias GK, Ioannidis JP, Aringer M, Bollen E, Bombardieri S, Bruce IN, Cervera R, Dalakas M, Doria A, Hanly JG, Huizinga TW, Isenberg D, Kallenberg C, Piette JC, Schneider M, Scolding N, Smolen J, Stara A, Tassiulas I, Tektonidou M, Tincani A, van Buchem MA, van Vollenhoven R, Ward M, Gordon C, Boumpas DT. EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs. Ann Rheum Dis. 2010;69(12):2074\u201382.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"632_CR101","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s40265-015-0534-3","volume":"76","author":"C Magro-Checa","year":"2016","unstructured":"Magro-Checa C, Zirkzee EJ, Huizinga TW, Steup-Beekman GM. Management of neuropsychiatric systemic lupus erythematosus: current approaches and future perspectives. Drugs. 2016;76(4):459\u201383.","journal-title":"Drugs"},{"key":"632_CR102","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1136\/annrheumdis-2011-201089","volume":"71","author":"JG Hanly","year":"2012","unstructured":"Hanly JG, Urowitz MB, Su L, et al. Seizure disorders in systemic lupus erythematosus results from an international, prospective, inception cohort study. Ann Rheum Dis. 2012;71:1502\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"632_CR103","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1136\/ard.2007.077594","volume":"67","author":"RM Andrade","year":"2008","unstructured":"Andrade RM, Alarcon GS, Gonzalez LA, et al. Seizures in patients with systemic lupus erythematosus: data from LUMINA, a multiethnic cohort (LUMINA LIV). Ann Rheum Dis. 2008;67(6):829\u201334.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"632_CR104","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1177\/0961203316674820","volume":"26","author":"N Sarbu","year":"2017","unstructured":"Sarbu N, Toledano P, Calvo A, Roura E, Sarbu MI, Espinosa G, Llad\u00f3 X, Cervera R, Bargall\u00f3 N. Advanced MRI techniques: biomarkers in neuropsychiatric lupus. Lupus. 2017;26(5):510\u20136.","journal-title":"Lupus"},{"issue":"3","key":"632_CR105","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1002\/art.27289","volume":"62","author":"H Jung","year":"2010","unstructured":"Jung H, Bobba R, Su J, Shariati-Sarabi Z, Gladman DD, Urowitz M, Lou W, Fortin PR. The protective effect of antimalarial drugs on thrombovascular events in systemic lupus erythematosus. Arthrit Rheum. 2010;62(3):863\u20138.","journal-title":"Arthrit Rheum"},{"issue":"4","key":"632_CR106","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1136\/ard.2004.025528","volume":"64","author":"L Barile-Fabris","year":"2005","unstructured":"Barile-Fabris L, Ariza-Andraca R, Olgu\u00edn-Ortega L, Jara LJ, Fraga-Mouret A, Miranda-Lim\u00f3n JM, Fuentes de la Mata J, Clark P, Vargas F, Alocer-Varela J. Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus. Ann Rheum Dis. 2005;64(4):620\u20135.","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"632_CR107","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1002\/art.1780370907","volume":"37","author":"SD Denburg","year":"1994","unstructured":"Denburg SD, Carbotte RM, Denburg JA. Corticosteroids and neuropsychological functioning in patients with systemic lupus erythematosus. Arthrit Rheum. 1994;37(9):1311\u201320.","journal-title":"Arthrit Rheum"},{"issue":"1","key":"632_CR108","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.semarthrit.2020.12.004","volume":"51","author":"DA Papachristos","year":"2021","unstructured":"Papachristos DA, Oon S, Hanly JG, Nikpour M. Management of inflammatory neurologic and psychiatric manifestations of systemic lupus erythematosus: a systematic review. Semin Arthrit Rheum. 2021;51(1):49\u201371.","journal-title":"Semin Arthrit Rheum"},{"issue":"2","key":"632_CR109","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/j.1755-3768.2008.01193.x","volume":"87","author":"YC Lin","year":"2009","unstructured":"Lin YC, Wang AG, Yen MY. Systemic lupus erythematosus-associated optic neuritis: clinical experience and literature review. Acta Ophthalmol. 2009;87(2):204\u201310.","journal-title":"Acta Ophthalmol"},{"issue":"5","key":"632_CR110","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1007\/BF00878876","volume":"242","author":"V Harisdangkul","year":"1995","unstructured":"Harisdangkul V, Doorenbos D, Subramony SH. Lupus transverse myelopathy: better outcome with early recognition and aggressive high-dose intravenous corticosteroid pulse treatment. J Neurol. 1995;242(5):326\u201331.","journal-title":"J Neurol"},{"issue":"296","key":"632_CR111","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1093\/qjmed\/81.3.975","volume":"81","author":"DT Boumpas","year":"1991","unstructured":"Boumpas DT, Yamada H, Patronas NJ, Scott D, Klippel JH, Balow JE. Pulse cyclophosphamide for severe neuropsychiatric lupus. Q J Med. 1991;81(296):975\u201384.","journal-title":"Q J Med"},{"issue":"2","key":"632_CR112","first-page":"432","volume":"26","author":"V Baca","year":"1999","unstructured":"Baca V, Lavalle C, Garc\u00eda R, Catal\u00e1n T, Sauceda JM, S\u00e1nchez G, Mart\u00ednez I, Ram\u00edrez ML, M\u00e1rquez LM, Rojas JC. Favorable response to intravenous methylprednisolone and cyclophosphamide in children with severe neuropsychiatric lupus. J Rheumatol. 1999;26(2):432\u20139.","journal-title":"J Rheumatol"},{"issue":"4","key":"632_CR113","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1136\/ard.2004.025528","volume":"64","author":"L Barile-Fabris","year":"2005","unstructured":"Barile-Fabris L, Ariza-Andraca R, Olguin-Ortega L, Jara LJ, Fraga-Mouret A, Miranda-Limon JM, et al. Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus. Ann Rheum Dis. 2005;64(4):620\u20135.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"632_CR114","doi-asserted-by":"publisher","first-page":"513","DOI":"10.3899\/jrheum.121096","volume":"40","author":"LS Lim","year":"2013","unstructured":"Lim LS, Lefebvre A, Benseler S, Silverman ED. Longterm outcomes and damage accrual in patients with childhood systemic lupus erythematosus with psychosis and severe cognitive dysfunction. J Rheumatol. 2013;40(4):513\u20139.","journal-title":"J Rheumatol"},{"issue":"5","key":"632_CR115","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1080\/03009740701607042","volume":"36","author":"CC Mok","year":"2007","unstructured":"Mok CC. Mycophenolate mofetil for non-renal manifestations of systemic lupus erythematosus: a systematic review. Scand J Rheumatol. 2007;36(5):329\u201337.","journal-title":"Scand J Rheumatol"},{"issue":"7","key":"632_CR116","first-page":"764","volume":"114","author":"Y Dong","year":"2001","unstructured":"Dong Y, Zhang X, Tang F, Tian X, Zhao Y, Zhang F. Intrathecal injection with methotrexate plus dexamethasone in the treatment of central nervous system involvement in systemic lupus erythematosus. Chin Med J (Engl). 2001;114(7):764\u20136.","journal-title":"Chin Med J (Engl)"},{"issue":"2","key":"632_CR117","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1007\/s12013-014-0010-9","volume":"70","author":"J Wang","year":"2014","unstructured":"Wang J, Zhao Y, Zhang J, Lei H, Zhu G, Fu B. Impact analysis of autoantibody level and NR2 antibody level in neuropsychiatric SLE treated by methylprednisolone combined with MTX and DXM intrathecal injection. Cell Biochem Biophys. 2014;70(2):1005\u20139.","journal-title":"Cell Biochem Biophys"},{"issue":"3","key":"632_CR118","first-page":"397","volume":"25","author":"V Germano","year":"2011","unstructured":"Germano V, Picchianti Diamanti A, Ferlito C, Podest\u00e0 E, Salemi S, Migliore A, D\u2019Amelio R, Lagan\u00e0 B. Cyclosporine A in the long-term management of systemic lupus erythematosus. J Biol Regul Homeost Agents. 2011;25(3):397\u2013403.","journal-title":"J Biol Regul Homeost Agents"},{"issue":"11","key":"632_CR119","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1046\/j.1525-1594.2000.06623.x","volume":"24","author":"R Bambauer","year":"2000","unstructured":"Bambauer R, Schwarze U, Schiel R. Cyclosporin A and therapeutic plasma exchange in the treatment of severe systemic lupus erythematosus. Artif Organs. 2000;24(11):852\u20136.","journal-title":"Artif Organs"},{"issue":"4","key":"632_CR120","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1136\/ard.2006.057885","volume":"66","author":"M Tokunaga","year":"2007","unstructured":"Tokunaga M, Saito K, Kawabata D, Imura Y, Fujii T, Nakayamada S, Tsujimura S, Nawata M, Iwata S, Azuma T, Mimori T, Tanaka Y. Efficacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system. Ann Rheum Dis. 2007;66(4):470\u20135.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"632_CR121","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1212\/WNL.0000000000000570","volume":"83","author":"RC Dale","year":"2014","unstructured":"Dale RC, Brilot F, Duffy LV, Twilt M, Waldman AT, Narula S, et al. Utility and safety of rituximab in pediatric autoimmune and inflammatory CNS disease. Neurology. 2014;83(2):142\u201350.","journal-title":"Neurology"},{"issue":"4","key":"632_CR122","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.humimm.2005.01.022","volume":"66","author":"E Toubi","year":"2005","unstructured":"Toubi E, Kessel A, Shoenfeld Y. High-dose intravenous immunoglobulins: an option in the treatment of systemic lupus erythematosus. Hum Immunol. 2005;66(4):395\u2013402.","journal-title":"Hum Immunol"},{"issue":"1","key":"632_CR123","first-page":"41","volume":"32","author":"I Camara","year":"2014","unstructured":"Camara I, Sciascia S, Simoes J, Pazzola G, Salas V, Karim Y, Roccatello D, Cuadrado MJ. Treatment with intravenous immunoglobulins in systemic lupus erythematosus: a series of 52 patients from a single centre. Clin Exp Rheumatol. 2014;32(1):41\u20137 (Epub 2013 Sep 12).","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"632_CR124","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/jca.21276","volume":"28","author":"J Schwartz","year":"2013","unstructured":"Schwartz J, Winters JL, Padmanabhan A, Balogun RA, Delaney M, Linenberger ML, Szczepiorkowski ZM, Williams ME, Wu Y, Shaz BH. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: the sixth special issue. J Clin Apher. 2013;28(3):145\u2013284.","journal-title":"J Clin Apher"},{"issue":"2","key":"632_CR125","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1046\/j.1526-0968.2003.00032.x","volume":"7","author":"CM Neuwelt","year":"2003","unstructured":"Neuwelt CM. The role of plasmapheresis in the treatment of severe central nervous system neuropsychiatric systemic lupus erythematosus. Ther Apher Dial. 2003;7(2):173\u201382.","journal-title":"Ther Apher Dial"},{"issue":"5","key":"632_CR126","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1001\/jama.295.5.527","volume":"295","author":"RK Burt","year":"2006","unstructured":"Burt RK, Traynor A, Statkute L, Barr WG, Rosa R, Schroeder J, Verda L, Krosnjar N, Quigley K, Yaung K, Villa Bs M, Takahashi M, Jovanovic B, Oyama Y. Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus. JAMA. 2006;295(5):527\u201335.","journal-title":"JAMA"},{"issue":"11","key":"632_CR127","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1136\/annrheumdis-2011-200831","volume":"71","author":"S Manzi","year":"2012","unstructured":"Manzi S, S\u00e1nchez-Guerrero J, Merrill JT, Furie R, Gladman D, Navarra SV, et al. Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined results from two phase III trials. Ann Rheum Dis. 2012;71(11):1833\u20138.","journal-title":"Ann Rheum Dis"},{"issue":"25","key":"632_CR128","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000034079","volume":"102","author":"Y Liu","year":"2023","unstructured":"Liu Y, Fan Q, Jia C, Wan Q, Yang H. Clinical efficacy of belimumab in central nervous system demyelinating syndromes with systemic lupus erythematosus: a case series. Medicine (Baltimore). 2023;102(25): e34079.","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"632_CR129","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1093\/mrcr\/rxab003","volume":"6","author":"T Kodera","year":"2022","unstructured":"Kodera T, Tsutsumi T, Oka Y, Takeda T, Shirota Y, Kameoka J. Clinical efficacy of belimumab in patients with systemic lupus erythematosus and headache. A report of two cases. Mod Rheumatol Case Rep. 2022;6(1):25\u20138.","journal-title":"Mod Rheumatol Case Rep."},{"issue":"5","key":"632_CR130","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.jpeds.2006.03.011","volume":"148","author":"JL Huggins","year":"2006","unstructured":"Huggins JL, Brunner HI. Targeting B cells in the treatment of childhood-onset systemic lupus erythematosus. J Pediatr. 2006;148(5):571\u20133.","journal-title":"J Pediatr"},{"issue":"2","key":"632_CR131","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1177\/0961203319896018","volume":"29","author":"A Segarra","year":"2020","unstructured":"Segarra A, Arredondo KV, Jaramillo J, Jatem E, Salcedo MT, Agraz I, et al. Efficacy and safety of bortezomib in refractory lupus nephritis: a single-center experience. Lupus. 2020;29(2):118\u201325.","journal-title":"Lupus"},{"issue":"7","key":"632_CR132","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1007\/s10067-023-06559-y","volume":"42","author":"RF Modica","year":"2023","unstructured":"Modica RF, Thatayatikom A, Bell-Brunson DH, Elder ME. Bortezomib is efficacious in the treatment of severe childhood-onset neuropsychiatric systemic lupus erythematosus with psychosis: a case series and mini-review of B cell immunomodulation in antibody-mediated diseases. Clin Rheumatol. 2023;42(7):1965\u201379.","journal-title":"Clin Rheumatol"},{"issue":"9","key":"632_CR133","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.3389\/fimmu.2018.02189","volume":"26","author":"EV Mike","year":"2018","unstructured":"Mike EV, Makinde HM, Der E, Stock A, Gulinello M, Gadhvi GT, Winter DR, Cuda CM, Putterman C. Neuropsychiatric systemic lupus erythematosus is dependent on sphingosine-1-phosphate signaling. Front Immunol. 2018;26(9):2189.","journal-title":"Front Immunol"},{"issue":"10","key":"632_CR134","doi-asserted-by":"publisher","first-page":"2554","DOI":"10.1084\/jem.20180776","volume":"215","author":"J Nestor","year":"2018","unstructured":"Nestor J, Arinuma Y, Huerta TS, Kowal C, Nasiri E, Kello N, Fujieda Y, Bialas A, Hammond T, Sriram U, Stevens B, Huerta PT, Volpe BT, Diamond B. Lupus antibodies induce behavioral changes mediated by microglia and blocked by ACE inhibitors. J Exp Med. 2018;215(10):2554\u201366.","journal-title":"J Exp Med"},{"issue":"6","key":"632_CR135","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1096\/fj.09-138834","volume":"24","author":"A Jacob","year":"2010","unstructured":"Jacob A, Hack B, Chiang E, Garcia JG, Quigg RJ, Alexander JJ. C5a alters blood\u2013brain barrier integrity in experimental lupus. FASEB J. 2010;24(6):1682\u20138.","journal-title":"FASEB J"},{"issue":"1","key":"632_CR136","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1111\/imm.12489","volume":"146","author":"SD Mahajan","year":"2015","unstructured":"Mahajan SD, Parikh NU, Woodruff TM, Jarvis JN, Lopez M, Hennon T, Cunningham P, Quigg RJ, Schwartz SA, Alexander JJ. C5a alters blood-brain barrier integrity in a human in vitro model of systemic lupus erythematosus. Immunology. 2015;146(1):130\u201343.","journal-title":"Immunology"},{"issue":"3","key":"632_CR137","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1002\/art.27289","volume":"62","author":"H Jung","year":"2010","unstructured":"Jung H, Bobba R, Su J, Shariati-Sarabi Z, Gladman DD, Urowitz M, et al. The protective effect of antimalarial drugs on thrombovascular events in systemic lupus erythematosus. Arthrit Rheum. 2010;62(3):863\u20138.","journal-title":"Arthrit Rheum"},{"issue":"2","key":"632_CR138","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/art.23334","volume":"59","author":"T Avcin","year":"2008","unstructured":"Avcin T, Benseler SM, Tyrrell PN, Cucnik S, Silverman ED. A followup study of antiphospholipid antibodies and associated neuropsychiatric manifestations in 137 children with systemic lupus erythematosus. Arthrit Rheum. 2008;59(2):206\u201313.","journal-title":"Arthrit Rheum"},{"issue":"2","key":"632_CR139","doi-asserted-by":"publisher","first-page":"163","DOI":"10.46497\/ArchRheumatol.2023.41875","volume":"38","author":"A Bahar Kele\u015fo\u011flu Din\u00e7er","year":"2023","unstructured":"Bahar Kele\u015fo\u011flu Din\u00e7er A, Erkan D. The ABCs of antiphospholipid syndrome. Arch Rheumatol. 2023;38(2):163\u201373.","journal-title":"Arch Rheumatol."},{"issue":"2","key":"632_CR140","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1212\/01.WNL.0000149640.78684.EA","volume":"64","author":"E McLaurin","year":"2005","unstructured":"McLaurin E, Holliday S, Williams P, Brey R. Predictors of cognitive dysfunction in patients with systemic lupus erythematosus. Neurology. 2005;64(2):297\u2013303.","journal-title":"Neurology"},{"issue":"11","key":"632_CR141","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1136\/ard.2004.029926","volume":"64","author":"M Haupt","year":"2005","unstructured":"Haupt M, Millen S, J\u00e4nner M, Falagan D, Fischer-Betz R, Schneider M. Improvement of coping abilities in patients with systemic lupus erythematosus: a prospective study. Ann Rheum Dis. 2005;64(11):1618\u201323.","journal-title":"Ann Rheum Dis"}],"container-title":["Pediatric Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-024-00632-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40272-024-00632-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-024-00632-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T07:40:45Z","timestamp":1718955645000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40272-024-00632-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,28]]},"references-count":141,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["632"],"URL":"https:\/\/doi.org\/10.1007\/s40272-024-00632-y","relation":{},"ISSN":["1174-5878","1179-2019"],"issn-type":[{"value":"1174-5878","type":"print"},{"value":"1179-2019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,28]]},"assertion":[{"value":"25 April 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author did not received support from any organization for the submitted work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"None declared.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"None.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"All authors wrote sections of the first draft. All authors reviewed and approved final version.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}